NICE offers advice on fractures drug

NICE issued advice last week on the fracture prevention treatment denosumab, the diabetes drug liraglutide and the cardiovascular treatment clopidogrel.

The institute backed denosumab (Prolia) for some postmenopausal women at increased risk of osteoporotic fractures if other NHS treatments are unsuitable.

NICE has also issued final guidance approving the use of the drug liraglutide for some diabetes patients. PCTs must now fund the drug for eligible patients whose clinicians wish to prescribe it.

The treatment can be given to patients with a BMI over 35 if other treatments have failed, or those with a BMI under 35 if they are not suitable for insulin. The institute has also backed wider use of clopidogrel and dipyridamole for preventing occlusive vascular events.

In guidance now out for consultation, clopidogrel can be offered to patients who have had ischaemic stroke, peripheral arterial disease or multivascular disease. But it is only recommended for MI if aspirin is unsuitable.

Modified-release dipyridamole plus aspirin may be considered for patients who have had a TIA, NICE says.

For stroke patients, this should be recommended only when clopidogrel is not tolerated or contraindicated. It should be offered alone only when treatment with clopidogrel and aspirin are unsuitable in this patient group.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Boris Johnson, Sajid Javid and NHS chief executive Amanda Pritchard at Downing Street press conference

GPs offered £15 per jab as government sets 31 January COVID-19 booster deadline

COVID-19 vaccine payments to GP practices will rise nearly a fifth to £15 per jab...

Houses of parliament

Evidence for mandatory NHS staff COVID-19 jabs 'not good enough', says Lords committee

Evidence to support government plans to require all NHS staff in patient-facing roles...

Dr Farah Jameel

Practices 'need substantial support' to step up Omicron response, warns BMA GP chair

General practice is already facing unsustainable pressure and will need 'substantial...

JCVI COVID-19 immunisation chair Professor Wei Shen Lim

JCVI backs immediate expansion of COVID-19 vaccination to combat Omicron variant

The COVID-19 booster campaign should expand immediately to people aged 18-39 and...

Close up of hand holding sample tube with 'Omicron' handwritten on side

Government urged to 'free up' GP practices and expand steps to control Omicron

GPs have called for immediate action such as suspension of QOF to allow practices...

(Photo: Mike Kemp/Getty Images)

Coronavirus: Key guidance GPs need to know about COVID-19

GPonline provides an overview of the key guidance relating to coronavirus, including...